Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study. - Wikidata - wikimedia - TriplyDB

Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.

Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.

http://www.wikidata.org/entity/Q37442961

about

Intestinal manometry: who needs it?How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach.

P2860

Q26782840-C3301A5C-FA85-48A2-9E6D-01BB97C28EC6 Q38701265-5D7E204C-79C1-4A52-B49D-050E68E97D73

P2860

Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.

http://www.wikidata.org/entity/Q37442961

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.

@en

Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.

@nl

type

label

Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.

@en

Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.

@nl

prefLabel

Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.

@en

Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.

@nl

P1433

Q37442961-A3A151B8-5FFD-4717-9A28-4F6F06FC4967

P1476

Q37442961-8635F3FF-731F-44EC-BEF2-0769AC1EC635

P2093

Q37442961-17331EEE-D722-4CCA-82AA-0D669601615F

Q37442961-357794F8-0AE2-4403-997F-9164555880E6

Q37442961-803813ED-B809-4B38-873A-1B40234BBB62

Q37442961-D0310E36-AE32-44DA-ADC3-73740AA23490

Q37442961-FF25CFA0-2CE7-4015-A8A9-499907EEFA61

P2860

Q37442961-22A4D41D-E74A-452C-A39C-024F29CFF380

Q37442961-4B605CBB-5E30-4D25-91DF-F4092B8FFB25

Q37442961-50D6C905-1C08-4D99-B319-5C0308862C5B

Q37442961-534E59AB-C8F1-491C-BC5B-DF37A04AA1C1

Q37442961-5554B267-7C28-4A3A-912F-C1AEA7C46148

Q37442961-5ED14365-B99B-47FF-A697-B2CFA0062304

Q37442961-7F1282FE-6D6F-45EF-808A-360754075C49

Q37442961-8033424D-6FEB-45C6-B040-B13D31D481FC

Q37442961-81AB28D7-6830-48AF-9129-96EB5BDDE696

Q37442961-87CED2CA-A9C1-4AEE-A1BB-0AEC579B755D

P2888

Q37442961-0CA8402E-83A7-43DB-A476-DB5254B00BAC

P304

Q37442961-7C99085E-DC86-4402-A5D7-83334DD288CA

P31

Q37442961-761BFD06-B7E3-438D-891B-0F25E5050AEF

P356

Q37442961-3C93F672-0A2A-4DA3-8A54-2AB0675F6D6D

P407

Q37442961-CACEF0BB-489F-48EB-95B2-D612A34A7E02

P433

Q37442961-4184E9D7-7C64-4469-9AA5-CF42D1655BF0

P478

Q37442961-15ED9D20-2F9A-42D2-84A5-A8F3CAF8CAF3

P577

Q37442961-62963F5B-723B-4D78-8F36-27FC668C3B6F

P5875

Q37442961-12A48B8A-D56D-469B-B8E6-55AA176CF895

P698

Q37442961-1BEBCBA6-BE3D-473E-AA7E-024DF339856C

P932

Q37442961-6C730855-DE52-406B-B9E4-4451127B3D23

P356

S12664-009-0048-6

P1433

Indian Journal of Gastroenterology

P1476

Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.

@en

P2093

Ashok Attaluri

http://www.w3.org/2001/XMLSchema#string

Issam Nasr

http://www.w3.org/2001/XMLSchema#string

Robert Summers

http://www.w3.org/2001/XMLSchema#string

Satish S C Rao

http://www.w3.org/2001/XMLSchema#string

Syed M A Hashmi

http://www.w3.org/2001/XMLSchema#string

P2860

5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake.

Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial

Pharmacokinetic data and drug monitoring: I. Antibiotics and antiarrhythmics.

Integrated modelling of the clinical pharmacokinetics of SDZ HTF 919, a novel selective 5-HT4 receptor agonist, following oral and intravenous administration.

Causes and treatment of functional dyspepsia.

Basic and clinical pharmacology of new motility promoting agents.

Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis.

Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.

Oral erythromycin and symptomatic relief of gastroparesis: a systematic review.

Systemic review: the prevalence and clinical course of functional dyspepsia.

P2888

s12664-009-0048-6

P304

136-142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12664-009-0048-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40030437

http://www.w3.org/2001/XMLSchema#string

P698

19937173

http://www.w3.org/2001/XMLSchema#string

P932

3883142

http://www.w3.org/2001/XMLSchema#string